Regeneron Pharmaceuticals 1 article

The scientific profile of Regeneron Pharmaceuticals combines antibody therapeutics with VelocImmune antibody discovery platform, placing the company in targeted biologic drug development. The company links Regeneron Genetics Center with human genetics target discovery; allergic and inflammatory disease therapeutics shows how antibody format or binding architecture is translated into a biological effect. GenoMethods keeps antibody formats, molecular targets and individual biologics separate from the company; the protein-therapeutics profile of Regeneron Pharmaceuticals also includes oncology immunotherapy antibodies.